Ditchcarbon
  • Contact
  1. Organizations
  2. HanchorBio Inc.
Public Profile
Pharmaceutical Preparation Manufacturing
TW
updated a month ago

HanchorBio Inc.

Company website

HanchorBio Inc., a leading biotechnology firm headquartered in Taiwan (TW), has been at the forefront of innovative solutions since its establishment. Specialising in advanced biopharmaceuticals and cutting-edge research, the company operates primarily in the Asia-Pacific region, with a growing presence in global markets. Founded in 2015, HanchorBio has achieved significant milestones, including the development of unique therapeutic products that address unmet medical needs. Their core offerings, which include monoclonal antibodies and biologics, are distinguished by their precision and efficacy, setting new standards in the industry. With a strong commitment to research and development, HanchorBio has positioned itself as a key player in the biopharmaceutical landscape, recognised for its contributions to healthcare advancements and patient outcomes.

DitchCarbon Score

How does HanchorBio Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

17

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

32

Industry Benchmark

HanchorBio Inc.'s score of 17 is lower than 88% of the industry. This can give you a sense of how well the company is doing compared to its peers.

12%

Let us know if this data was useful to you

HanchorBio Inc.'s reported carbon emissions

In 2024, HanchorBio Inc., headquartered in Taiwan (TW), reported total carbon emissions of approximately 54,110,000 kg CO2e. This figure includes 2,966,000 kg CO2e from Scope 1 emissions, 340,000 kg CO2e from Scope 2 emissions, and a significant 50,804,000 kg CO2e from Scope 3 emissions. Despite the substantial emissions reported, there are currently no specific reduction targets or climate pledges documented for HanchorBio Inc. This lack of defined initiatives may reflect a broader industry context where many organisations are still developing comprehensive climate strategies. HanchorBio Inc. does not inherit emissions data from any parent company, indicating that their reported figures are solely their own. The company has not disclosed any additional information regarding their climate commitments or reduction initiatives.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. HanchorBio Inc.'s primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for HanchorBio Inc. is in TW, which we do not have grid emissions data for.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

HanchorBio Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Adagene Inc.

CN
•
Pharmaceutical Preparation Manufacturing
Updated 25 days ago

ALX Oncology Holdings Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated 28 days ago

Beijing Mabworks Biotech Co., Ltd.

CN
Updated 3 days ago

GeneScience Pharmaceuticals Co., Ltd.

CN
•
Pharmaceutical Preparation Manufacturing
Updated 6 days ago

Phanes Therapeutics, Inc.

US
•
Research and development services (73)
Updated about 2 months ago

Akeso Biopharma, Inc.

CN
•
Pharmaceutical Preparation Manufacturing
Updated 4 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v251008.2
[email protected]+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
UL Solutions verification badge
CDP logo
Gartner Cool Vendor 2025 badge
ProductPortalScope 3 Tool FunctionalityDataIntegrationsPricing
CustomersHaleonGrant ThorntonHikmaRead all stories
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesCalculation MethodologyDocumentationBlogFAQOrganizationsIndustriesSBTI APITrust CentreChangelog
AboutTeamCareersLicense AgreementPrivacy